Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Plast Reconstr Surg Glob Open ; 11(8): e5196, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37588477

ABSTRACT

Background: Of 7461 actively practicing United States American Board of Plastic Surgery certified plastic surgeons, only 17% are women. In relation to this small number, gender inequities within the field have been the source of national discussions. Our study assessed the status of the gender-based wage-gap in plastic surgery and sought to identify possible causes. Methods: An anonymous 43-question survey was distributed to 2981 members of the American Society of Plastic Surgeons in 2021. Male and female responses were compared; an analysis also considering board-certification year was performed. Chi-square and Fisher exact tests were used for bivariate analysis. Continuous variables were compared with two-sample t tests and Wilcoxon rank sum tests. Results: Ten percent of contacted American Society of Plastic Surgeons members responded to our survey. Of the 288 respondents, 111 (38.5%) were women, and 177 (61.5%) were men. Men were more likely to have salaries over $400K USD per year (P < 0.0001). Earlier certification year was associated with pay greater than $400K per year (P = 0.0235) but was insignificant once stratified by gender (women: P = 0.2392, men: P = 0.7268). Earlier certification year was associated with production-based and self-determined wages (P = 0.0097), whereas later board-certification year was associated with nonnegotiable salaries (P < 0.0001). Conclusions: Women are significantly less likely to make salaries comparable to those of male plastic surgeons, related to shorter careers on average. An increase in female representation and career duration within the field is needed to improve the current wage-gap.

2.
Plast Reconstr Surg Glob Open ; 9(10): e3850, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34646720

ABSTRACT

Morel-Lavallée lesions have been described in the literature since the mid-19th century, yet contemporary clinical management continues to be challenging and remains variable. These closed degloving injuries are usually seen in the setting of blunt trauma and are due to shearing forces, creating a space for the collection of hemolymphatic fluid. These fluid collections can be persistent despite conservative treatment attempts and can require staged surgical interventions. METHODS: A literature search of peer-reviewed articles pertaining to Morel-Lavallée lesions was performed. Articles relating to the pathophysiology, clinical presentation, diagnosis, treatment, and management of complications of Morel-Lavallée lesions were included to formulate recommendations for clinical management. RESULTS: Fifty-six relevant articles were included in the review. Recognition of these lesions may be delayed and the use of imaging is important in diagnosis. Initial attempts at conservative management may be appropriate for smaller, uncomplicated Morel-Lavallée lesions. Surgical interventions such as open debridement, techniques to close dead space, negative pressure wound therapy, and skin grafts or flaps are critical to managing complex or recurring lesions. An algorithm for the treatment of Morel-Lavallée lesions is proposed based on review of the literature. CONCLUSIONS: Plastic and reconstructive surgeons are frequently involved in more complex Morel-Lavallée lesions such as those exhibiting delayed healing or super-infection. The skillset needed for successful management of patients with Morel-Lavallée lesions is well within the armamentarium of plastic and reconstructive surgeons.

3.
Plast Surg (Oakv) ; 29(1): 16-20, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33614536

ABSTRACT

INTRODUCTION: Abdominal wall morbidity after microsurgical breast reconstruction is an important consideration for patients and surgeons. Previous studies are limited by multiple mesh locations or types. In this study, we evaluate specifically subfascial polypropylene mesh placement to determine a more definitive complication rate and basis for objective comparison. METHODS: A retrospective review was performed for patients undergoing microsurgical breast reconstruction at our institution by 3 surgeons from 2015 to 2018. All patients with sublay placement of polypropylene mesh were included. Patient demographics, medical comorbidities, type of reconstruction, and postoperative abdominal wall complications were recorded. RESULTS: A total of 114 flaps were performed on 81 patients who met the inclusion criteria. Of these, 48 were deep inferior epigastric artery (DIEP) flaps (42%), 43 were MS-2 TRAM flaps (37.8%), 20 were muscle sparing (MS-1) transverse rectus abdominus muscle (TRAM) flaps (17.5%), and 3 were free TRAM flaps (2.6%). Average follow-up was 392 days (range: 29-1191). Average body mass index was 30.7. No patients developed hernias. Two patients (2.5%) complained of post-operative bulges, neither of which required operative treatment. Two patients experienced superficial abdominal wall infection, one of which required admission and intravenous antibiotics. Ten patients (12.3%) had abdominal incision dehiscence, 3 of which required operative intervention. There were no cases of mesh exposure, contamination, or removal. CONCLUSION: Polypropylene mesh is safe and effective, with subfascial placement resulting in low morbidity and low rates of bulge/hernia formation after microsurgical breast reconstruction. Consideration should be given to using polypropylene mesh for fascial repairs after microsurgical breast reconstruction, particularly in high-risk populations.


INTRODUCTION: Les patientes et les chirurgiens doivent tenir compte de la possibilité d'affections de la paroi abdominale après une reconstruction mammaire microchirurgicale. Les études antérieures sont limitées par la multiplicité des emplacements et des types de treillis. Dans la présente étude, les chercheurs évaluent l'installation sous-aponévrotique d'un treillis de polypropylène pour obtenir un taux de complications plus catégorique et une référence en vue d'une comparaison objective. MÉTHODOLOGIE: Les chercheurs ont procédé à une analyse rétrospective des patientes qui ont subi une reconstruction mammaire microchirurgicale effectuée par trois chirurgiens dans leur établissement entre 2015 et 2018. Toutes les patientes ayant un treillis de polypropylène en sous-couche y ont participé. Les chercheurs ont pris note des caractéristiques démographiques des patientes, de leurs autres affections, du type de reconstruction et de leurs complications postopératoires. RÉSULTATS: Au total, 114 lambeaux reconstruits sur 81 patientes respectaient les critères d'inclusion. De ce nombre, 48 étaient des lambeaux de l'artère épigastrique inférieure profonde (42 %), 43, des lambeaux du muscle grand droit abdominal avec épargne musculaire 2 (37,8 %), 20, des lambeaux du muscle grand droit abdominal avec épargne musculaire 1 (17,5 %) et trois, des lambeaux du muscle grand droit (2,6 %). La période de suivi moyenne était de 392 jours (plage de 29 à 1 191), et l'indice de masse corporelle, de 30,7. Aucune patiente n'a fait de hernie. Deux patientes (2,5 %) se sont plaintes de bosses postopératoires, mais ni l'une ni l'autre n'a nécessité de traitement opératoire. Deux patientes ont souffert d'une infection abdominale superficielle, dont l'une a entraîné une hospitalisation et l'administration d'antibiotiques par voie intraveineuse. Dix patientes (12,3 %) ont présenté une déhiscence de l'incision abdominale, et trois ont dû subir une intervention opératoire. Il n'y a eu aucun cas d'exposition, de contamination ou d'exérèse du treillis. CONCLUSION: Le treillis de polypropylène est sécuritaire et efficace, et son installation sous-aponévrotique est liée à une faible morbidité et à un faible taux de formations de bosses ou de hernies après une reconstruction mammaire microchirurgicale. Il faut envisager de l'utiliser pour les réparations du fascia après une reconstruction mammaire microchirurgicale, particulièrement dans les populations à haut risque.

4.
Plast Reconstr Surg Glob Open ; 8(12): e3273, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33425588

ABSTRACT

Oncoplastic breast reconstruction addresses lumpectomy or partial mastectomy defects after breast conserving surgery. A large subset of breast cancer patients may be candidates for oncoplastic partial breast reconstruction, but are likely underserved in the United States due to multiple factors. In this article, the authors provide an understanding of current trends in the literature and an overview of key areas for improvement in the delivery of breast cancer surgical care. METHODS: A literature search of peer-reviewed articles relating to oncoplastic breast reconstruction was performed. In addition, current US laws relating to breast reconstruction, and communication and content from key surgical societies were reviewed. Key areas of improvement were identified after qualitative review of all sources. RESULTS: Thirty-four relevant resources were included. There is a large potential population need for oncoplastic breast reconstruction, but no current accurate estimate of patients undergoing this type of reconstruction. There are a multitude of definitions and algorithms attempting to define and organize oncoplastic breast surgery. Legislative initiatives could be improved to prevent coverage gaps. Coding and billing for oncoplastic surgery is not standardized, which complicates both clinical implementation and research efforts. Collaboration between national societies is needed. CONCLUSIONS: Oncoplastic partial breast reconstruction is an important part of the total package of care that can be offered to the breast cancer patient. Improvements in legislation, coding, and billing, and unification of national society communications and initiatives can lead to better surgical outcomes for the breast cancer patient.

5.
J Reconstr Microsurg ; 34(3): 185-192, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29129038

ABSTRACT

BACKGROUND: Free flaps have a well-established role in breast reconstruction after mastectomy; however, their role in partial breast reconstruction remains poorly defined. We reviewed our experience with partial breast reconstruction to better understand indications for free tissue transfer. METHODS: A retrospective review was performed of all patients undergoing partial breast reconstruction at our center between February 2009 and October 2015. We evaluated the characteristics of patients who underwent volume displacement procedures versus volume replacement procedures and free versus pedicled flap reconstruction. RESULTS: There were 78 partial breast reconstructions, with 52 reductions/tissue rearrangements (displacement group) and 26 flaps (replacement group). Bra cup size and body mass index (BMI) were significantly smaller in the replacement group. Fifteen pedicled and 11 free flaps were performed. Most pedicled flaps (80.0%) were used for lateral or upper pole defects. Most free flaps (72.7%) were used for medial and inferior defects or when there was inadequate donor tissue for a pedicled flap. Complications included hematoma, cellulitis, and one aborted pedicled flap. CONCLUSION: Free and pedicled flaps are useful for partial breast reconstruction, particularly in breast cancer patients with small breasts undergoing breast-conserving treatment (BCT). Flap selection depends on defect size, location, and donor tissue availability. Medial defects are difficult to reconstruct using pedicled flaps due to arc of rotation and intervening breast tissue. Free tissue transfer can overcome these obstacles. Confirming negative margins before flap reconstruction ensures harvest of adequate volume and avoids later re-operation. Judicious use of free flaps for oncoplastic reconstruction expands the possibility for breast conservation.


Subject(s)
Breast Neoplasms/surgery , Free Tissue Flaps/blood supply , Graft Survival/physiology , Mammaplasty , Mastectomy, Segmental , Adult , Body Mass Index , Esthetics , Female , Humans , Mammaplasty/methods , Middle Aged , Nipples/physiology , Nipples/surgery , Retrospective Studies , Treatment Outcome
6.
J Reconstr Microsurg ; 33(1): 59-62, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27595187

ABSTRACT

Background The medial sural vessels have been used extensively as donor vessels in free tissue transfer; however, there is sparse literature detailing their use as recipient vessels. The few existing reports involve small numbers of patients and describe operative approaches that are unnecessarily cumbersome. We explored our experience in free tissue transfer to the medial sural vessels and share a simplified operative approach to this recipient site. Methods A retrospective review was performed of all patients who underwent free tissue transfers to the medial sural vessels between December 2012 and December 2015 at a single institution. Preoperative imaging, operative approach, and technique for microvascular free tissue transfer to the medial sural vessels were reviewed. Postoperative results and complications were also analyzed. Results Using preoperative magnetic resonance angiography (MRA) to image the medial sural vessels and a retrograde perforator dissection technique, we successfully performed free tissue transfer to the distal medial sural vessels in 20 of 21 patients, representing the largest series reported. Postoperatively, 13 of 21 patients underwent MRA with a patent vascular pedicle demonstrated in all. There were no postoperative complications or resultant morbidities. Conclusion Surgeons should be aware of the medial sural vessels as a valuable recipient option for free tissue transfer to the lower extremity.


Subject(s)
Free Tissue Flaps/blood supply , Leg/blood supply , Microsurgery , Plastic Surgery Procedures/methods , Soft Tissue Injuries/surgery , Female , Graft Survival , Humans , Leg/diagnostic imaging , Leg/surgery , Male , Retrospective Studies , Soft Tissue Injuries/diagnostic imaging , Soft Tissue Injuries/physiopathology , Treatment Outcome
7.
J Surg Oncol ; 115(1): 90-95, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27976365

ABSTRACT

BACKGROUND: The use of heterotopic vascularized lymph node transfer (HVLNT) for the treatment of lower extremity lymphedema is still evolving. Current techniques, either place the lymph nodes in the thigh without a skin paddle or at the ankle requiring an unsightly and often bulky skin paddle for closure. We explored the feasibility of doing a below-knee transfer without a skin paddle using the medial sural vessels as recipient vessels and report our experience in 21 patients. METHODS: A retrospective review of all patients who underwent HVLNT to the medial calf was performed. Postoperative magnetic resonance angiography (MRA) and lymphoscintigraphy (LS) were analyzed to assess lymph node viability and function after transfer. RESULTS: Twenty-one patients underwent HVLNT to the medial calf. Postoperative imaging was performed at an average of 11 months after surgery. Thirteen patients had postoperative MRA, of whom 12 demonstrated viable lymph nodes. Seven patients underwent postoperative LS, of whom three demonstrated uptake in the transferred nodes. In the other four patients, the injectate failed to reach the level of the proximal calf. CONCLUSION: We provide proof of concept that HVLNT to the lower leg using the medial sural vessels without a skin paddle can result in viable and functional lymph nodes in the setting of lower extremity lymphedema. J. Surg. Oncol. 2017;115:90-95. © 2016 Wiley Periodicals, Inc.


Subject(s)
Lymph Nodes/transplantation , Lymphedema/surgery , Adult , Aged , Free Tissue Flaps/transplantation , Humans , Leg/surgery , Lymph Nodes/blood supply , Lymph Nodes/physiology , Middle Aged , Muscle, Skeletal/surgery , Retrospective Studies , Skin Transplantation , Transplantation, Heterotopic
SELECTION OF CITATIONS
SEARCH DETAIL
...